Novartis Corporation to Build $700 Million Biotech Plant in Singapore

October 29, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SINGAPORE, Oct 29 (Reuters) - Swiss pharmaceuticals group Novartis AG (NOVN.VX: Quote, Profile, Research) said on Monday it will build a $700 million cell culture plant in Singapore to support its growing biopharmaceutical business.

Twitter
LinkedIn
Facebook
Email
Print

Real estate Asia